Table 4.
Entry | Ligand | Hormonal Activity (U2OS Cells) a | Growth inhibition | ||||
---|---|---|---|---|---|---|---|
ERα | ERβ | IC50 after 96h [μM] | |||||
| |||||||
IA b [%] | CD c [%] | IA b [%] | CD c [%] | MCF7 | MDA-MB-231 | ||
1. | 11ZZ | −71 | 81 | −91 | 79 | 0.11 | >20 |
2. | 12ZZ | −64 | 80 | −89 | 78 | 0.07 | 1.84 |
3. | 13ZZ | −83 | 51 | −93 | 55 | 0.11 | 1.95 |
4. | 14ZZ | −85 | 61 | −96 | 59 | 0.06 | 1.23 |
5. | 15ZZ | −95 | 15 | −99 | 15 | 0.08 | 1.20 |
6. | 16ZZ | −100 | 10 | −99 | 9 | 0.10 | 0.69 |
7. | 17ZZ | −100 | 9 | −100 | 8 | 2.10 | 13.98 |
8. | 19ZZ | −100 | 8 | −100 | 7 | 0.01 | 0.32 |
9. | 19 d | −99 | 8 | −100 | 6 | 0.15 | 0.32 |
10. | 20Z | −42 | - | −77 | - | 0.37 | 2.17 |
11. | 20E | - | - | - | - | 0.40 | 1.94 |
12. | OHT e | 5 | 110 | −47 | 92 | 0.15 | 4.59 |
Concentration 10μM.
Intrinsic activity (IA).
Cell density (CD).
Cell assays were evaluated based on Z-Z:Z-E:E-E = 1:2:1 isomers.
The concentration was 1μM.